Entity usage

Showing below up to 50 results in range #51 to #100.

51. Quantifying degrees of necessity and of sufficiency in cause-effect relationships with dichotomous and survival outcomes: Label: en
52. Estimation tools for reducing the impact of sampling and nonresponse errors in dual-frame RDD telephone surveys: Label: en
53. A joint model for multiple dynamic processes and clinical endpoints: application to Alzheimer's disease: Label: en
54. Information content of stepped-wedge designs when treatment effect heterogeneity and/or implementation periods are present: Label: en
55. Variable selection in competing risks models based on quantile regression: Label: en
56. An additive boundary for group sequential designs with connection to conditional error: Label: en
57. Analysis of linear transformation models with covariate measurement error and interval censoring: Label: en
58. Robust semiparametric gene-environment interaction analysis using sparse boosting: Label: en
59. On the analysis of two-phase designs in cluster-correlated data settings: Label: en
60. A new perspective on loss to follow-up in failure time and life history studies: Label: en
61. Decomposition feature selection with applications in detecting correlated biomarkers of bipolar disorders: Label: en
62. Bayesian consensus-based sample size criteria for binomial proportions: Label: en
63. Nonparametric estimation of the spatio-temporal covariance structure: Label: en
64. Modeling excess deaths after a natural disaster with application to hurricane Maria: Label: en
65. Accounting for established predictors with the multistep elastic net: Label: en
66. Regression analysis and variable selection for two-stage multiple-infection group testing data: Label: en
67. Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials: Label: en
68. Impact of model misspecification in shared frailty survival models: Label: en
69. Maximum likelihood estimation with missing outcomes: from simplicity to complexity: Label: en
70. PSICA: decision trees for probabilistic subgroup identification with categorical treatments: Label: en
71. Identifying and interpreting subgroups in health care utilization data with count mixture regression models: Label: en
72. Untangling serially dependent underreported count data for gender-based violence: Label: en
73. Exposure density sampling: dynamic matching with respect to a time-dependent exposure: Label: en
74. Controlling false discovery proportion in identification of drug-related adverse events from multiple system organ classes: Label: en
75. A modelling approach for correcting reporting delays in disease surveillance data: Label: en
76. Design and analysis of nested case-control studies for recurrent events subject to a terminal event: Label: en
77. Continuous-time causal mediation analysis: Label: en
78. Reconciling randomized trial evidence on proximal versus distal outcomes, with application to trials of influenza vaccination for healthcare workers: Label: en
79. Stein-type shrinkage estimators in gamma regression model with application to prostate cancer data: Label: en
80. Assessment of heterogeneity in an individual participant data meta-analysis of prediction models: an overview and illustration: Label: en
81. Joint modeling of progression-free and overall survival and computation of correlation measures: Label: en
82. Two-tailed significance tests for \(2 \times 2\) contingency tables: what is the alternative?: Label: en
83. Measuring variability between clusters by subgroup: an extension of the median odds ratio: Label: en
84. On the self-triggering Cox model for recurrent event data: Label: en
85. Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease: Label: en
86. A comment on ``A plea to stop using the case-control design in retrospective database studies: Label: en
87. Considerations for outcome-dependent biased sampling in health databases: Label: en
88. Discussion of Schuemie et al.: ``A plea to stop using the case-control design in retrospective database studies: Label: en
89. A plea to stop using the case-control design in retrospective database studies: Label: en
90. The batched stepped wedge design: a design robust to delays in cluster recruitment: Label: en
91. Propensity score methods for observational studies with clustered data: a review: Label: en
92. Real time monitoring and prediction of time to endpoint maturation in clinical trials: Label: en
93. Bayesian model of disease progression in mucopolysaccaridosis IIIA: Label: en
94. Self-reporting and screening: data with right-censored, left-censored, and complete observations: Label: en
95. Dynamic prediction with time-dependent marker in survival analysis using supervised functional principal component analysis: Label: en
96. On optimal biomarker cutoffs accounting for misclassification costs in diagnostic trilemmas with applications to pancreatic cancer: Label: en
97. The impact of methodological choices when developing predictive models using urinary metabolite data: Label: en
98. Differential expression of single-cell RNA-seq data using Tweedie models: Label: en
99. Analyzing cohort studies with interval-censored data: a new model-based linear rank-type test: Label: en
100. Accounting for publication bias using a bivariate trim and fill meta-analysis procedure: Label: en